| 日期 | 主要股東
| 每股
平均價 | 類型 | 買/賣或涉及
股份數目 | 變動股數
佔已發行股(%) | 目前持股量 | 佔已
發行股(%) |
| 2025-06-23 | 吳永謙 | | 1701 (L) | 50,259,832(L) | N/A | 50259832(L) | 52.78(L) |
| 2025-06-23 | 吳永謙 | | 1701 (L) | 80,597,797(L) | N/A | 80597797(L) | 26.72(L) |
| 2025-06-23 | 國投創業投資管理有限公司 | | 1701 (L) | N/A | N/A | 21680081(L) | 7.19(L) |
| 2025-06-23 | 上海金浦醫療健康股權投資基金管理有限公司 | | 1701 (L) | 17,153,860(L) | N/A | 17153860(L) | 5.69(L) |
| 2025-06-23 | 先進製造產業投資基金二期(有限合夥) | | 1701 (L) | N/A | N/A | 24274756(L) | 8.05(L) |
| 2025-06-23 | 南京藥石科技股份有限公司 | | 1701 (L) | N/A | N/A | 22107247(L) | 7.33(L) |
| 2025-06-23 | Shanghai Guoxin Investment Development Co., Ltd. | | 1701 (L) | 8,314,088(L) | N/A | 8314088(L) | 8.73(L) |
| 2025-06-23 | CPE Management International II Limited | | 1701 (L) | N/A | N/A | 21521091(L) | 22.60(L) |
| 2025-06-23 | CPE Management International Limited | | 1701 (L) | N/A | N/A | 21521091(L) | 22.60(L) |
| 2025-06-23 | CPE Funds IV Limited | | 1701 (L) | N/A | N/A | 21521091(L) | 22.60(L) |
| 2025-06-23 | CPEChina Fund IV, L.P. | | 1701 (L) | N/A | N/A | 21521091(L) | 22.60(L) |
| 2025-06-23 | Cayenne Private Enterprise IV Limited | | 1701 (L) | N/A | N/A | 21521091(L) | 22.60(L) |
| 2025-06-23 | CPE Investment (Hong Kong) 2021 Limited | | 1701 (L) | N/A | N/A | 21521091(L) | 22.60(L) |
| 2025-06-23 | 南京益鏷生物科技合夥企業(有限合夥) | | 1701 (L) | 27,363,076(L) | N/A | 27363076(L) | 28.73(L) |
| 2025-06-23 | 南京益鏷生物科技合夥企業(有限合夥) | | 1701 (L) | 27,363,076(L) | N/A | 27363076(L) | 9.07(L) |